Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

FRA/BM8 stock hub

FRA/BM8 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/BM8is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

8.9B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/BM8

In the news

Latest news · FRA/BM8

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E9.3

P25 12.3P50 15.7P75 20.2

Trailing P/E38.1

P25 16.4P50 20.9P75 30.4

ROE4.5

P25 -6.7P50 8.5P75 17.2

ROIC7.4

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/BM8 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

219

Groups with data

Currency

USD

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	3,221
Employees Change	-361%
Employees Change Percent	-10.61
Enterprise value	EUR 8.2B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	US09061G1013
Last refreshed	2026-05-10
Market cap	EUR 8.9B
Price	EUR 46.12
Price currency	EUR
Rev Per Employee	873,039.64x
Sector	Healthcare
Sic	2836
Symbol	fra/BM8
Website	https://www.biomarin.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.63%
EV Earnings	35.23x
EV/EBIT	17.11x
EV/EBITDA	15.06x
EV/FCF	12.34x
EV/Sales	2.98x
FCF yield	7.49%
Forward P/E	9.29x
P/B ratio	1.65x
P/E ratio	38.08x
P/S ratio	3.16x
PE Ratio3 Y	60.93x
PE Ratio5 Y	150.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.42%
EBITDA Margin	19.47%
FCF margin	23.66%
Gross margin	51.16%
Gross Profit	EUR 1.4B
Gross Profit Growth	0.97%
Gross Profit Growth Q	-9.76%
Gross Profit Growth3 Y	17.97%
Gross Profit Growth5 Y	19.64%
Net Income	EUR 233.1M
Net Income Growth	-48.7%
Net Income Growth Q	-43.17%
Net Income Growth3 Y	55.4%
Net Income Growth5 Y	-19.5%
Pretax Margin	11.89%
Profit Margin	8.29%
Profit Per Employee	EUR 72,363
ROA	4.49
Roa5y	2.28
ROCE	7.24
ROE	4.48
Roe5y	3.83
ROIC	7.43
Roic5y	3.88

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-4.16%
Cagr15y	6.78%
Cagr1y	-13.45%
Cagr20y	7.94%
Cagr3y	-18.93%
Cagr5y	-6.72%
EPS Growth	-48.33
EPS Growth Q	-43.42
EPS Growth3 Y	55.68
EPS Growth5 Y	-19.74
FCF Growth	22.89%
FCF Growth Q	26.71%
FCF Growth3 Y	192.02%
FCF Growth5 Y	46.21%
OCF Growth	24.85%
OCF Growth Q	26.52%
OCF Growth3 Y	81.01%
OCF Growth5 Y	32.5%
Revenue Growth	9.9x
Revenue Growth Q	2.83x
Revenue Growth3 Y	14.27x
Revenue Growth5 Y	11.94x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.41
Assets	EUR 7.5B
Cash	EUR 1.9B
Current Assets	EUR 3.9B
Current Liabilities	EUR 672.6M
Debt	EUR 1.2B
Debt EBITDA	EUR 2.24
Debt Equity	EUR 0.23
Debt FCF	EUR 1.88
Equity	EUR 5.4B
Interest Coverage	24.56
Liabilities	EUR 2.1B
Long Term Assets	EUR 3.5B
Long Term Liabilities	EUR 1.4B
Net Cash	EUR 679M
Net Cash By Market Cap	EUR 7.65
Net Cash Growth	18.17%
Net Debt EBITDA	EUR -1.24
Net Debt Equity	EUR -0.13
Net Debt FCF	EUR -1.02
Tangible Book Value	EUR 5B
Tangible Book Value Per Share	EUR 26.08

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.81
Inventory Turnover	1.24
Net Working Capital	EUR 1.4B
Quick ratio	3.94
Working Capital	EUR 3.3B
Working Capital Turnover	EUR 0.85

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.86%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-34.61%
1Y total return	-13.44%
200-day SMA	48.03
3Y total return	-46.72%
50-day SMA	48.34
50-day SMA vs 200-day SMA	50over200
5Y total return	-29.37%
All Time High	140.5
All Time High Change	-67.18%
All Time High Date	2015-07-20
All Time Low	3.02
All Time Low Change	1,427.15%
All Time Low Date	2004-11-05
ATR	0.72
Ch YTD	-9.11
High	46.12
High52	55.66
High52 Date	2025-08-05
High52ch	-17.14%
Low	46.1
Low52	43.86
Low52 Date	2025-12-18
Low52ch	5.15%
Ma50ch	-4.59%
Price vs 200-day SMA	-3.98%
RSI	45.65
RSI Monthly	37.97
RSI Weekly	44.09
Sharpe ratio	-0.4x
Sortino ratio	-0.45
Total Return	-0.86%
Tr YTD	-9.11
Tr15y	167.36%
Tr1m	-4.18%
Tr1w	-1.96%
Tr3m	-3.92%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 489.8M
Operating Income Growth	-21.1
Operating Income Growth Q	-38.52
Operating Income Growth3 Y	78.02
Operating margin	17.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	192,153,823%
Net Borrowing	720,767,700
Shares Insiders	0.49%
Shares Institutions	97.14%
Shares Qo Q	2.83%
Shares Yo Y	0.86%
Short Ratio	4.94

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 502.9M
Average Volume	92.15x
Bv Per Share	27.88
CAPEX	EUR -93M
Ch10y	-34.61
Ch15y	167.4
Ch1m	-4.18
Ch1w	-1.96
Ch1y	-13.44
Ch20y	361.2
Ch3m	-3.92
Ch3y	-46.72
Ch5y	-29.37
Ch6m	4.82
Change	-0.39%
Change From Open	0.04
Close	46.3
Days Gap	-0.43
Depreciation Amortization	56,388,625
Dollar Volume	2,121.5
Earnings Date	2026-04-24
EBIT	EUR 489.8M
EBITDA	EUR 547.5M
EPS	EUR 1.21
F Score	5
FCF	EUR 665.3M
FCF EV Yield	8.1x
Financing CF	702,124,450
Fiscal Year End	December
Founded	1,996
Goodwill	166,369,296.4
Graham Number	27.61736
Graham Upside	-40.12
Income Tax	EUR 101.3M
Investing CF	294,469,165
Is Primary Listing	0
Last Earnings Date	2026-02-23
Last Report Date	2026-03-31
Lynch Fair Value	EUR 6.05
Lynch Upside	-86.87
Ma150	47.79
Ma150ch	-3.5%
Ma20	46.34
Ma20ch	-0.48%
Net CF	1,755,096,034
Open	46.1
P FCF Ratio	13.34
P OCF Ratio	11.71
Position In Range	100
Ppne	812,407,801.3
Price Date	2026-05-08
Price EBITDA	EUR 16.21
Ptbv Ratio	1.76
Relative Volume	0.49x
Revenue	2,812,060,667x
SBC By Revenue	5.77x
Share Based Comp	162,329,939
Tax By Revenue	3.6x
Tax Rate	30.3%
Tr20y	361.2%
Tr6m	4.82%
Volume	46
Z Score	3.94

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/BM8 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/BM8 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/BM8?

Insider, institutional, and short-interest positioning.

Institutional ownership

+97.1%

Share of float held by funds and institutions

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/BM8 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.6

Neutral momentum band

Price vs 200-day MA

-4.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.40

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/BM8

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/BM8 stock rating?

fra/BM8 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/BM8 analysis?

The full report lives at /stocks/fra/BM8/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/BM8?

The latest report frames fra/BM8 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/BM8 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.